Procter & Gamble Company (PG) Stock
NYSEPG has an Alpha Score of 60 out of 100 (moderate), computed on Oct 28, 2026 from 4 of 4 sub-scores. 75 members of Congress disclosed 237 trades in PG since 2012: 141 purchases and 96 sales, most recently David J. Taylor (sale, Oct 12, 2026). 7 of the hedge funds AlphaScala tracks reported PG in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Point72's at $633.92M. Company insiders reported 0 open-market buys and 21 sales on SEC Form 4 in the 90 days to Oct 30, 2026. Its trailing P/E ratio is 22.8 and its net margin 18.4% (key statistics as of Oct 22, 2026).
What is PG's Alpha Score?
How it works →Alpha Score of 59 reflects moderate overall profile with strong momentum, weak value, moderate quality, moderate sentiment.
Computed Oct 28, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded Procter & Gamble Company (PG)?
Most recent: David J. Taylor (sale, Oct 12, 2026); records start Aug 16, 2012.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Dave Taylor R-OH · House | 2026-10-12 | sale | $1k – $15k |
| Pete Sessions R-TX · House | 2026-10-08 | sale | $1k – $15k |
| Dave Taylor R-OH · House | 2026-09-08 | purchase | $1k – $15k |
| Kevin Hern R-OK · House | 2026-08-24 | sale | $50k – $100k |
| Lloyd Doggett D-TX · House | 2026-08-17 | purchase | $1k – $15k |
| Dave Taylor R-OH · House | 2026-08-11 | purchase | $1k – $15k |
| Kevin Hern R-OK · House | 2026-08-05 | sale | $1k – $15k |
| Rich McCormick R-GA · House | 2026-07-30 | sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 29, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
Every member of Congress who traded PG, with filing lags →Which hedge funds own PG?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Point72 Steve Cohen | 4.32M | $633.92M | +106% |
| Fundsmith Terry Smith | 4.08M | $598.05M | -3% |
| Citadel Ken Griffin | 2.91M | $426.11M | +324% |
| Millennium Management Israel Englander | 1.48M | $217.43M | +43% |
| D.E. Shaw David Shaw | 755K | $110.68M | -69% |
| Bridgewater Associates Ray Dalio | 138K | $20.20M | -13% |
| Marshall Wace | 9K | $1.38M | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Procter & Gamble Company insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 23, 26 | Gama Paul | CEO- Health Care | SELL | 4.3K | $698K |
| Oct 23, 26 | Purushothaman Balaji | Chief Human Resources Officer | SELL | 4.2K | $672K |
| Oct 23, 26 | Jejurikar Shailesh | Chairman, President and CEO | SELL | 35.0K | $5.7M |
| Oct 5, 26 | Whaley Susan Street | Chief Legal Officer & Secy | SELL | 2.4K | $344K |
| Oct 5, 26 | Gama Paul | CEO- Health Care | SELL | 2.2K | $323K |
| Oct 5, 26 | Schulten Andre | Chief Financial Officer | SELL | 3.9K | $569K |
| Aug 24, 26 | Janzaruk Matthew W. | SVP - Chief Accounting Officer | SELL | 359 | $52K |
| Aug 21, 26 | Raman Sundar G. | CEO-Fabric Home & Habitat Care | SELL | 3.4K | $491K |
| Aug 20, 26 | Pritchard Marc S. | Chief Brand Officer | SELL | 4.0K | $579K |
| Aug 20, 26 | Whaley Susan Street | Chief Legal Officer & Secy | SELL | 2.2K | $322K |
SEC Form 4 filings as of Oct 30, 2026
See cluster-buy signals across all tickers →What are PG's key statistics?
Key statistics as of Oct 22, 2026
How does PG's valuation compare with the Consumer Staples sector?
| Metric | PG | Consumer Staples median | Companies in median |
|---|---|---|---|
| P/E ratio | 22.8 | 19.8 | 60 |
| Net margin | 18.43% | 6.34% | 64 |
| Return on equity | 29.83% | 14.14% | 64 |
| Dividend yield (payers) | 2.49% | 2.68% | 49 |
Medians over the Consumer Staples stocks whose key statistics were refreshed in the last 35 days (newest Nov 2, 2026). P/E excludes loss-making companies.
What did Procter & Gamble Company's latest SEC filings say?
Latest 5Procter & Gamble Announces Quarterly Dividend of $1.0885 Per Share for Shareholders
On April 14, 2026, The Procter & Gamble Company filed an 8-K report to announce that its Board of Directors has declared a quarterly dividend. The dividend is set at $1.0885 per share. This distribution applies to the company's Common Stock as well as its Series A and Series B ESOP Convertible Class A Preferred Stock. The dividend is scheduled to be paid on or after May 15, 2026. Shareholders of record for the Common Stock must be on the company's books at the close of business on April 24, 2026. For holders of Series A and Series B ESOP Convertible Class A Preferred Stock, the record date is the start of business on April 24, 2026. This filing was submitted under Item 7.01, Regulation FD Disclosure, to provide public notice of the dividend declaration.
- ›Board of Directors declared a quarterly dividend of $1.0885 per share.
- ›Dividend applies to Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock.
- ›Payment date for the dividend is on or after May 15, 2026.
- ›Record date for Common Stock is the close of business on April 24, 2026.
- ›Record date for preferred stock is the start of business on April 24, 2026.
Procter & Gamble Reports Second Quarter Fiscal 2026 Financial Results and Operational Data
Procter & Gamble filed its Form 10-Q for the second quarter of fiscal year 2026, covering the period ending December 31, 2025. The filing details the company's financial position and operational structure across its five primary reportable segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The document provides extensive data on debt instruments, including various notes due between 2026 and 2045, and outlines the company's approach to pension plans and postretirement benefits. The filing includes sensitivity analyses regarding the Gillette indefinite-lived intangible assets, specifically modeling the impact of fluctuations in discount rates, long-term growth rates, and royalty rates. The company maintains its established segment reporting structure and continues to manage risks associated with product concentration across its diverse portfolio of consumer goods. The report confirms the company's ongoing financial activities, including common stock transactions and treasury stock adjustments, consistent with its capital allocation strategy.
- ›Maintained five core operating segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
- ›Provided updated sensitivity analysis for Gillette indefinite-lived intangible assets regarding discount and growth rate assumptions.
- ›Detailed ongoing debt obligations with maturity dates extending through 2045.
- ›Continued reporting of defined benefit pension and other postretirement benefit plan obligations.
- ›Confirmed consistent capital allocation activities including common stock and treasury stock adjustments.
Procter and Gamble Files Form 8-K Reporting Financial Results for December 2025 Quarter
The Procter and Gamble Company filed an 8-K on January 22, 2026, to formally announce the release of its financial results for the fiscal quarter ended December 31, 2025. The filing serves as a regulatory notification under Item 2.02, Results of Operations and Financial Condition, confirming that the company has issued a news release detailing its performance for the period. The 8-K does not contain the specific financial data within the body of the filing itself, but instead incorporates the earnings news release by reference as Exhibit 99.1. The document confirms the company's compliance with SEC reporting requirements following the conclusion of its most recent fiscal quarter.
- ›The company released financial results for the quarter ended December 31, 2025.
- ›The filing serves as a formal notification of earnings release under Item 2.02.
- ›The company provided a news release as Exhibit 99.1 to detail operational performance.
Procter & Gamble Files Regulation FD Disclosure Regarding Second Quarter Financial Results Presentation
On January 22, 2026, The Procter & Gamble Company filed an 8-K report under Item 7.01, Regulation FD Disclosure. The filing serves to formally provide the public with informational slides that were referenced during the company's conference call held on the same day. These slides were utilized by management to discuss the company's financial performance for the second quarter of the 2026 fiscal year. The document confirms that the materials are available on the company's investor relations website. No other material events or operational changes were reported in this specific filing.
- ›The company released informational slides regarding second quarter 2026 financial results.
- ›Management conducted a conference call to discuss the quarterly performance.
- ›The filing was submitted under Regulation FD to ensure public access to presentation materials.
Procter & Gamble Announces Quarterly Dividend Declaration for Common and Preferred Stockholders
On January 13, 2026, The Procter & Gamble Company filed an 8-K to announce that its Board of Directors has declared a quarterly dividend. The dividend is set at $1.0568 per share. This payment applies to the company's Common Stock as well as its Series A and Series B ESOP Convertible Class A Preferred Stock. The dividend is scheduled to be paid on or after February 17, 2026. Shareholders of record for the Common Stock must be on the books at the close of business on January 23, 2026. Shareholders of record for the Series A and Series B ESOP Convertible Class A Preferred Stock must be on the books at the start of business on January 23, 2026. The filing was submitted under Item 7.01, Regulation FD Disclosure, to provide public notice of this corporate action.
- ›Board of Directors declared a quarterly dividend of $1.0568 per share.
- ›Dividend applies to Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock.
- ›Payment date for the dividend is scheduled for February 17, 2026.
- ›Record date for Common Stock is January 23, 2026, at the close of business.
- ›Record date for Series A and Series B Preferred Stock is January 23, 2026, at the start of business.
PG price chart
Powered by TradingViewWhat does Procter & Gamble Company do?
The Procter & Gamble Company is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, and founded in 1837. It manufactures and markets a diverse portfolio of leading branded products across five key segments: Beauty, featuring shampoos and treatments like Head & Shoulders, Pantene, and Olay; Grooming, including Gillette razors and Braun appliances; Health Care, with oral care brands such as Crest and Oral-B, plus Vicks and Pepto-Bismol; Fabric & Home Care, encompassing detergents like Tide and Ariel, plus Febreze and Dawn; and Baby, Feminine & Family Care, offering Pampers diapers, Always feminine products, and Charmin toilet paper. These brands often hold dominant market shares exceeding 25% in their categories, generating over $85 billion in annual sales, with more than 20 exceeding $1 billion each. Procter & Gamble distributes worldwide, with roughly half its revenue from outside the U.S., serving households through everyday essentials that emphasize quality and innovation. Employing about 109,000 people, it ranks among the largest firms in the consumer defensive sector, focusing on household and personal products.